TAU Discovers Experimental Compound Effective in Treating Symptoms of Autism and Alzheimer’s Disease
An extensive international study led by Tel Aviv University found that an experimental drug which has been awarded orphan drug designation by the FDA for future treatment of a rare development disorder can also treat a variety of symptoms relating to autism, intellectual disability, and Alzheimer’s disease. The experimental drug, NAP, was discovered in…